Select conditions below to toggle them from the plot:
GROUP | CONDITION | SAMPLES |
---|---|---|
Peripheral blood mononuclear cells (PBMC) |
GSM4749840 GSM4749841 GSM4749842 GSM4749843 GSM4749844 GSM4749845
|
|
GSM4749816 GSM4749817 GSM4749818 GSM4749819 GSM4749820
|
||
GSM4749821 GSM4749822 GSM4749823 GSM4749824 GSM4749825 GSM4749826 GSM4749827
|
||
GSM4749834 GSM4749835 GSM4749836 GSM4749837 GSM4749838 GSM4749839
|
||
GSM4749828 GSM4749829 GSM4749830 GSM4749831 GSM4749832 GSM4749833
|
Submission Date: Aug 27, 2020
Summary: We identified that PBMC of individuals simultaneously affected by a combination of T2DM, dyslipidemia and periodontitis, showed altered molecular profile mainly associated to inflammatory response, immune cell trafficking, and infectious disease pathways
Patients were divided into: T2DMpoorly-DL-P (n=5, Grupo 1), T2DMwell-DL-P (n=7, Grupo 2), DL-P (n=6, Grupo 3), P (n=6, Grupo 4) and Healthy (n=6, Control). T2DM poorly controlled = HbA1c ≥8.5%; T2DM well-controlled patients = HbA1c <7.0%
GEO Accession ID: GSE156993
PMID: No Pubmed ID
Submission Date: Aug 27, 2020
Summary: We identified that PBMC of individuals simultaneously affected by a combination of T2DM, dyslipidemia and periodontitis, showed altered molecular profile mainly associated to inflammatory response, immune cell trafficking, and infectious disease pathways
Patients were divided into: T2DMpoorly-DL-P (n=5, Grupo 1), T2DMwell-DL-P (n=7, Grupo 2), DL-P (n=6, Grupo 3), P (n=6, Grupo 4) and Healthy (n=6, Control). T2DM poorly controlled = HbA1c ≥8.5%; T2DM well-controlled patients = HbA1c <7.0%
GEO Accession ID: GSE156993
PMID: No Pubmed ID
Signatures:
Control Condition
Perturbation Condition
Only conditions with at least 1 replicate are available to select